Page 18 - GP Spring 2020

Upon recall appointment on the 7 day in po-Medrol) group, 80% of patients from in the sensory nerve fibers, which may in-
th
group III (antibiotic group), 3 (15%) pa- the saline-control group, and 85% of pa- crease in number during an inflammatory
tients reported severe pain, 4 patients had tients in the antibiotic group reported back situation. When the primary mode of anes-
moderate pain, 3 patients reported mild with vital pulp on the seventh day. There thesia is not achieved, various supplemental
pain, and 10 patients did not experience was no statistically significant difference in anesthetic techniques are used to achieve
There was a significant difference in pain experienced by patients on
any pain. 7 patients in this group took an- the vitality among groups I, II and III on adequate anesthesia such as intra-ligamen-
There was a significant difference in pain experienced by patients on
algesics from day one through day seven the 7 day. tary (periodontal ligament), intra-pulpal,
th
and did not experience any significant pain and intraosseous techniques. One of these
the seventh day among the four treatment groups. Methyl prednisolone acetate
relief. 2 patients experienced discomfort There was a significant difference in pain methods is the administration of anesthesia
the seventh day among the four treatment groups. Methyl prednisolone acetate
while performing pulpectomy under nerve experienced by patients on the seventh day by the intraosseous approach with different
intraosseous injection was the most effective in reducing pain.
block on the 7 day. In the remaining 18 among the four treatment groups. Methyl anesthetic drugs. When patients have se-
th
intraosseous injection was the most effective in reducing pain.
patients, pulpectomy was performed under prednisolone acetate intraosseous injection vere pain that needs to be controlled, an-
BAR GRAPH SHOWING THE NUMBER OF PATIENTS HAVING
nerve block without pain and discomfort. was the most effective in reducing pain. ti-inflammatory agents are advised to defer
BAR GRAPH SHOWING THE NUMBER OF PATIENTS HAVING
Complete pulpectomy was achieved in the treatment. Various studies have reported
these patients. PAIN FOR A DURATION OF 7 DAYS analgesics such
BAR GRAPH SHOWING THE NUMBER OF PATIENTS as benzodiaz-
In group IV, PAIN FOR A DURATION OF 7 DAYS epenes (triazol-
HAVING PAIN FOR A DURATION OF 7 DAYS
(2% lidocaine am, alprazolam
intraosseous in- and diazepam)
jection followed and NSAIDS in
by pulpectomy treating the pul-
on day 0), 6 pa- Depo-Medrol pal pain where
tients reported Depo-Medrol emer gency
Saline
to have pain and Saline pulpectomy is
discomfort on not achieved for
day 0 while per- Lidocaine pain reduction,
forming pulpec- Lidocaine in irreversible
tomy. Only par- pulpitis cases.
tial pulpectomy Clinicians have
was performed administrat -
in 3 patients due ed steroids by
to the inabil- intraosseous
ity to achieve BAR GRAPH SHOWING THE NUMBER OF PATIENTS HAVING administration
adequate anes- BAR GRAPH SHOWING THE NUMBER OF PATIENTS HAVING (Gallatin et
BAR GRAPH SHOWING THE NUMBER OF PATIENTS
thesia and the HAVING PERCUSSION PAIN FOR A DURATION OF 7 DAYS al., Bramy et
patients were PERCUSSION PAIN FOR A DURATION OF 7 DAYS al.) and orally
experiencing PERCUSSION PAIN FOR A DURATION OF 7 DAYS administered
pain. On day (Claffy et al.,
seven, 4 pa- Kérourédan et
tients (20%) al.). Steroids are
reported severe Depo-Medrol useful in reduc-
pain, 4 patients Depo-Medrol ing pain associ-
Saline
reported mod- Saline ated with acute
erate pain, 4 pa- Lidocaine irreversible pul-
tients reported Lidocaine pitis due to their
mild pain, and 8 anti-inflamma-
patients did not tory action by
experience any reducing PGE2
pain. 3 patients and IL-8 which
needed analge- are potent in-
sics. 2 patients fl a m m a t or y
had severe pain and discomfort during Discussion mediators in acute irreversible pulpitis. 10.
pulpectomy on the 7 day. Root canal treat- The success rate of local anesthesia for The purpose of using the Depo-Medrol in
th
ment was completed in the remaining 18 teeth with pulpal inflammation is reported the present study is to temporarily reduce
patients. In the other 2 patients, pulpecto- to be less than 20% or very poor. An ac- the patient’s symptoms until definitive end-
my was reattempted under nerve block and cepted hypothesis on how local anesthetic odontic treatment is performed. The pain-
the patient was recalled for continuing root drugs prevent action potential transmission ful symptoms might be reduced due to the
canal treatment. is that these drugs effectively blocks volt- anti-inflammatory effects of the corticoste-
age dependent gates in the length of nerve roid on the pulp.
Tooth vitality testing was done with elec- fibers and prevent action potential creation.
! "
##
tric pulp tester and Endo-Frost on day 0 and There are different types of voltage-depen- The Stabident intraosseous system was
! "
##
day 7 in groups I, II and III. 90% patients dent gates. One of these gates is the tetra- chosen to deliver methyl prednisolone ac-
from the methyl prednisolone acetate (De- dotoxin-resistant gate. These gates exists etate (Depo-Medrol) because of its con-

www.nysagd.org l Spring 2020 l GP 18